Catalyst Wire Dossier Catalyst Wire Dossier

DE-117 Ophthalmic Solution

DE-117 · Santen Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for DE-117 Ophthalmic Solution, covering 2016-06-29 to 2023-08-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study [Phase 3]

See pricing